Effects of soy vs. casein protein on body weight and glycemic control in female monkeys and their offspring

American Journal of Primatology

Volumn 71, Issue 9, 2009, Pages 802-811

  Wagner, Janice D ^a   Jorgensen, Matthew J ^a   Cline, J Mark ^a   Lees, Cynthia J ^a   Franke, Adrian A ^b   Zhang, Li ^a   Ayers, Melissa R ^a   Schultz, Carrie ^c   Kaplan, Jay R ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^c Purina Lab Diet   (United States)

Author keywords

Cynomolgus monkeys; Glucose; Insulin; Isoflavones; Lipids; Soy

Indexed keywords

CASEIN; FRUCTOSAMINE; INSULIN; ISOFLAVONE DERIVATIVE; LACTALBUMIN; LIPID;

BODY MASS; ESTROGENIC COMPOUND; GLUCOSE; HORMONE; LIPID; OBESITY; PHYSIOLOGICAL RESPONSE; PREGNANCY; PRIMATE; PROTEIN; SERUM; WEIGHT;

AGE; ANIMAL; ANIMAL FOOD; ARTICLE; BLOOD; BODY WEIGHT; CHEMISTRY; DRUG EFFECT; FEMALE; GLUCOSE TOLERANCE TEST; MACACA; METABOLISM; PREGNANCY; PRENATAL EXPOSURE; PROTEIN INTAKE; SOYBEAN;

AGE FACTORS; ANIMAL FEED; ANIMALS; BODY WEIGHT; CASEINS; DIETARY PROTEINS; FEMALE; FRUCTOSAMINE; GLUCOSE TOLERANCE TEST; INSULIN; ISOFLAVONES; LACTALBUMIN; LIPIDS; MACACA FASCICULARIS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; SOYBEANS;

ANIMALIA; MACACA FASCICULARIS;

EID: 69349083055     PISSN: 02752565     EISSN: 10982345     Source Type: Journal    
DOI: 10.1002/ajp.20716     Document Type: Article

References (55)

1. Abler A, Smith JA, Randazzo PA, Rothenberg PL, Jarett L. 1992. Genistein differentially inhibits postreceptor effects of insulin in rat adipocytes without inhibiting the insulin receptor kinase. J Biol Chem 267:3946-3951.
2. Adams MR, Golden DL, Williams JK, Franke AA, Register TC, Kaplan JR. 2005. Soy protein containing isoflavones reduces the size of atherosclerotic plaques without affecting coronary artery reactivity in adult male monkeys. J Nutr 135:2852-2856.
3. Arjmandi BH, Alekel L, Hollis BW, Amin D, Stacewicz-Sapuntzakis M, Guo P, Kukreja SC. 1996. Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis. J Nutr 126:161-167.
4. Badger TM, Ronis MJJ, Hakkak R, Rowlands JC, Korourian S. 2002. The health consequences of early soy consumption. J Nutr 132:559S-565S.
5. Baker JL, Olsen LW, Sørensen TIA. 2007. Childhood body-mass index and the risk of coronary heart disease in adulthood. New Engl J Med 357:2329-2337.
6. Barker DJB, editor. 1992. Fetal and infant origins of adult disease. London: BMJ Publishing Group.
7. Barker DJP, Bagby SP. 2005. Developmental antecedents of cardiovascular disease: a historical perspective. J Am Soc Nephrol 16:2537-2544.
8. Bhathena SJ, Velasquez MT. 2002. Beneficial role of dietary phytoestrogens in obesity and diabetes. Am J Clin Nutr 76:1191-1201.
9. Cederroth CR, Vinciguerra M, Gjinovci A, Kühne F, Klein M, Cederroth M, Caille D, Suter M, Neumann D, James RW, Doerge DR, Wallimann T, Meda P, Foti M, Rohner-Jeanrenaud F, Vassalli JD, Nef S. 2008. Dietary phytoestrogens activate AMP-activated protein kinase with improvement in lipid and glucose metabolism. Diabetes 57:1176-1185.
10. Clarkson TB, Anthony MS, Morgan TM. 2001. Inhibition of postmenopausal atherosclerosis progression: a comparison of the effects of conjugated equine estrogens and soy phytoestrogens. J Clin Endocrinol Metab 86:41-47.
11. Cline JM, Wood CE. 2009. Estrogen/isoflavone interactions in cynomolgus macaques (Macaca fascicularis). Am J Primatol 71:722-731.
12. Costrini NV, Kalkhoff RK. 1971. Relative effects of pregnancy, estradiol, and progesterone on plasma insulin and pancreatic islet insulin secretion. J Clin Invest 50:992-999.
13. Dang ZC, Audinot V, Papapoulos SE, Boutin JA, Lowik CW. 2003. Peroxisome proliferator-activated receptor gamma (PPARgamma) as a molecular target for the soy phytoestrogen genistein. J Biol Chem 278:962-967.
14. Delclos KB, Newbold R. 2007. NTP toxicity report of reproductive dose range-finding study of genistein (CAS No. 446-72-0) administered in feed to Sprague-Dawley rats. Toxic Rep Ser 79:1-C2.
15. DeStefano F, Ford ES, Newman J, Stevenson JM, Wetterhall SF, Anda RF, Vinicor F. 1993. Risk factors for coronary heart disease mortality among persons with diabetes. Ann Epidemiol 3:27-34.
16. Dolinoy DC, Weidman JR, Waterland RA, Jirtle RL. 2006. Maternal genistein alters coat color and protects Avy mouse offspring from obesity by modifying the fetal epigenome.Environ Health Perspect 114:567-572.
17. Franke AA, Custer LJ, Wilkens LR, Le Marchand LL, Nomura AM, Goodman MT, Kolonel LN. 2002. Liquid chromatographic-photodiode array mass spectrometric analysis of dietary phytoestrogens from human urine and blood. J Chromatogr B Analyt Technol Biomed Life Sci 777:45-59.
18. Franke AA, Halm BM, Custer LJ, Tatsumura Y, Hebshi S. 2006. Isoflavones in breastfed infants after mothers consume soy. Am J Clin Nutr 84:406-413.
19. Friedenwald J, Ruhrah J. 1910. The use of the soy bean as a food in diabetes. Am J Med Sci 140:793-803.
20. Goodman-Gruen D, Kritz-Silverstein D. 2001. Usual dietary isoflavone intake is associated with cardiovascular disease risk factors in postmenopausal women. J Nutr 131:1202-1206.
21. Gu L, House SE, Prior RL, Fang N, Ronis MJJ, Clarkson TB, Wilson ME, Badger TM. 2006. Metabolic phenotype of isoflavones differ among female rats, pigs, monkeys, and women. J Nutr 136:1215-1221.
22. Halm BM, Franke AA. 2004. Overweight and obesity, a worsening health problem particularly in children. Hawaii Med J 63:91-93.
23. Halm BM, Ashburn LA, Franke AA. 2007. Isoflavones from soya foods are more bioavailable in children than adults. Br J Nutr 98:998-1005.
24. Harmon AW, Harp JB. 2001. Differential effects of flavonoids on 3T3-L1 adipogenesis and lipolysis. Am J Physiol Cell Physiol 280:C807-C813.
25. Harmon AW, Patel YM, Harp JB. 2002. Genistein inhibits CCAAT/enhancer-binding protein beta (C/EBPbeta) activity and 3T3-L1 adipogenesis by increasing C/EBP homologous protein expression. Biochem J 367:203-208.
26. Hermansen K, Søndergaard M, Høie L, Carstensen M, Brock B. 2001. Beneficial effects of a soy-based dietary supplement on lipid levels and cardiovascular risk markers in type 2 diabetic subjects. Diabetes Care 24:228-233.
27. Hwang CS, Kwak HS, Lim HJ, Lee SH, Kang YS, Choe TB, Hur HG, Han KO. 2006. Isoflavone metabolites and their in vitro dual functions: they can act as an estrogenic agonist or antagonist depending on the estrogen concentration. J Steroid Biochem Mol Biol 101:246-253.
28. Iritani N, Sugimoto T, Fukuda H, Komiya M, Ikeda H. 1996. Dietary soybean protein increases insulin receptor gene expression in Wistar fatty rats when dietary polyunsaturated fatty acid level is low. J Nutr 127:1077-1083.
29. Jayagopal V, Albertazzi P, Kilpatrick ES, Howarth EM, Jennings PE, Hepburn DA, Atkin SL. 2002. Beneficial effects of soy phytoestrogen intake in postmenopausal women with type 2 diabetes. Diabetes Care 25:1709-1714.
30. Jensen MN, Ritskes-Hoitinga M. 2007. How isoflavone levels in common rodent diets can interfere with the value of animal models and with experimental results. Lab Animals 41:1-18.
31. Jonas JC, Plant TD, Gilon P, Detimary P, Nenquin M, Henquin JC. 1995. Multiple effects and stimulation of insulin secretion by the tyrosine kinase inhibitor genistein in normal mouse islets. Br J Pharmacol 114:872-880.
32. Kandulska K, Nogowski L, Szkudelski T. 1999. Effect of some phytoestrogens on metabolism of rat adipocytes. Reprod Nutr Dev 39:497-501.
33. Kannel WB, D'Agostino RB, Wilson PWF, Belanger AJ, Gagnon D. 1990. Diabetes, fibrinogen, and risk of cardiovascular disease: The Framingham experience. Am Heart J 120:672-676.
34. Kavanagh K, Jones KL, Zhang L, Flynn DM, Shadoan MK, Wagner JD. 2008. High isoflavone soy diet increases insulin secretion without decreasing insulin sensitivity in premenopausal nonhuman primates. Nutr Res 28:368-376.
35. Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA. 1998. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139;4252-4263.
36. Lamartiniere CA, Murrill WB, Manzolillo PA, Zhang JX,Barnes S, Zhang X, Wei H, Brown NM. 1998.Genistein alters the ontogeny of mammary gland development and protects against chemically-induced mammary cancer in rats.Proc Soc Exp Biol Med. 217:358-364.
37. Mackowiak P, Nogowski L, Nowak KW. 1999. Effect of isoflavone genistein on insulin receptors in perfused liver of ovariectomized rats. J Recept Signal Transduct Res 19:283-292.
38. Mezei O, Banz WJ, Steger RW, Peluso MR, Winters TA, Shay N. 2003. Soy isoflavones exert antidiabetic and hypolipidemic effects through the PPAR pathways in obese Zucker rats and murine RAW 264.7 cells. J Nutr 133:1238-1243.
39. Morito K, Aomori T, Hirose T, Kinjo J, Hasegawa J, Ogawa S, Inoue S, Muramatsu M, Masamune Y. 2002. Interaction of phytoestrogens with estrogen receptors alpha and beta (II).Biol Pharm Bull 25:48-52.
40. Pan Y, Anthony M, Watson S, Clarkson TB. 2000. Soy phytoestrogens improve radial arm maze performance in ovariectomized retired breeder rats and do not attenuate benefits of 17 b-estradiol treatment. Menopause 7:230-235.
41. Rasouli N, Kern PA. 2008. Adipocytokines and the metabolic complications of obesity. J Clin Endocrinol Metab 93:S64-S73.
42. Sakai T, Kogiso M. 2008. Soy isoflavones and immunity. J Med Invest 55:167-173.
43. Setchell KDR, Cassidy A. 1999. Dietary isoflavones: biological effects and relevance to human health. J Nutr 758S-767S.
44. Sharpe RM, Martin B, Morris K, Greig I, McKinnell C, McNeilly AS, Walker M. 2002. Infant feeding with soy formula milk: effects on the testis and on blood testosterone levels in marmoset monkeys during the period of neonatal testicular activity. Hum Reprod 17:1692-1703.
45. Smith RM, Tiesinga JJ, Shah N, Smith JA, Jarett L. 1993. Genistein inhibits insulin-stimulated glucose transport and decreases immunocytochemical labeling of GLUT4 carboxyl-terminus without affecting translocation of GLUT4 in isolated rat adipocytes: additional evidence of GLUT4 activation by insulin. Arch Biochem Biophys 300:238-246.
46. Sorenson RL, Brelje TC, Roth C. 1994. Effect of tyrosine kinase inhibitors on islets of Langerhans: evidence for tyrosine kinases in the regulation of insulin secretion.Endocrinology 134:1975-1978.
47. Stauffer BL, Konhilas JP, Luczak ED, Leinwand LA. 2006. Soy diet worsens heart disease in mice. J Clin Invest 116:209-216.
48. Stern MP, Haffner SM. 1986. Body fat distribution and hyperinsulinemia as risk factors for diabetes and cardiovascular disease. Arteriosclerosis 6:123-130.
49. Stroud FC, Appt SE, Wilson ME, Franke AA, Adams MR, Kaplan JR. 2006. Concentrations of isoflavones in macaques consuming standard laboratory monkey diet. J Am Assoc Lab Anim Sci 45:20-23.
50. Tan KA, Walker M, Morris K, Greig I, Mason JI, Sharpe RM. 2006. Infant feeding with soy formula milk: effects on puberty progression, reproductive function and testicular cell numbers in marmoset monkeys in adulthood. Hum Reprod 21:896-904.
51. Thigpen JE, Setchell KD, Ahlmark KB, Locklear J, Spahr T, Caviness GF, Goelz MF, Haseman JK, Newbold RR, Forsythe DB. 1999. Phytoestrogen content of purified, open- and closed-formula laboratory animal diets. Lab Anim Sci 49:530-536.
52. Wagner JD, Cefalu WT, Anthony MS, Litwak KN, Zhang L, Clarkson TB. 1997. Dietary soy protein and estrogen replacement therapy improve cardiovascular risk factors and decrease aortic cholesteryl ester content in ovariectomized cynomolgus monkeys. Metabolism 46:698-705.
53. Wagner JD, Zhang L, Greaves KA, Shadoan MK, Schwenke DC. 2000. Soy protein reduces the arterial low-density lipoprotein (LDL) concentration and delivery of LDL cholesterol to the arteries of diabetic and nondiabetic male cynomolgus monkeys. Metab-Clin Exp 49: 1188-1196.
54. Wagner JD, Anthony MS, Cline JM. 2001. Soy phytoestrogens: research on benefits and risks. Clin Obstet Gynecol 44:843-852.
55. Wagner JD, Zhang L, Shadoan MK, Kavanagh K, Chen H, Tresnasari K, Kaplan JR, Adams MR. 2008. Effects of soy protein and isoflavones on insulin resistance and adiponectin in male monkeys. Metabolism 57:S24-S31.